Abiopharma

🔍 Eizenman Liron (Executive)

Company: SILICOM LTD. (SILC)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Sold 18,072 shares of Ordinary shares at $48.53 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,928.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 38,333 shares of Restricted Share Units (Derivative)
  Date: 2026-08-12 | Code: H | shares_owned_after: 38,333.00 | Footnotes: F3, F4, F4, F2
• Holds 100,000 shares of Share Option (right to buy) at $16.42 per share (Derivative)
  Date: 2026-08-12 | Code: H | Expires: 2032-06-18 | shares_owned_after: 100,000.00 | Footnotes: F5, F2
• Holds 13,333 shares of Share Option (right to buy) at $15.01 per share (Derivative)
  Date: 2026-08-12 | Code: H | Expires: 2033-06-18 | shares_owned_after: 13,333.00 | Footnotes: F6, F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.50 to $48.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F2: These securities are held by a trustee pursuant to the Issuer's equity incentive plan.
• F3: Each restricted share unit (RSU) represents the right to receive, following vesting, one share of the Issuer.
• F4: The grant of the RSUs have been approved by the Company's Compensation Committee and Board of Directors. Vesting of the RSUs will be subject to the grantee's achievement of the specified performance condition and continued service through each applicable vesting date, (a) 12,778 of the RSUs will vest and convert into ordinary shares one year after the grant date (which grant date is January 29, 2026), (b) 12,778 of the RSUs will vest and convert into ordinary shares on the second annual anniversary of the grant date and (c) 12,777 of the RSUs will vest and convert into ordinary shares on the three year anniversary of the grant date. If a vesting date falls on a non-business date, the next business date shall apply.
• F5: Each option represents an option to purchase one share of the Issuer's ordinary shares upon vesting. The options were granted on June 18, 2024 (the "Grant Date") and will vest as follows: (a) 50% on the second annual anniversary of the Grant Date; and (b) 50% on the third annual anniversary of the Grant Date, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date.
• F6: Each option represents an option to purchase one share of the Issuer's ordinary shares upon vesting. The options were granted on June 18, 2025 (the "Grant Date") and will vest as follows: (a) 50% on the second annual anniversary of the Grant Date; and (b) 50% on the third annual anniversary of the Grant Date subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date.